medigraphic.com

2012, Number 4

<< Back

Rev Med Inst Mex Seguro Soc 2012; 50 (4)

Clinical guide practice. Patent ductus arteriosus

San Luis-Miranda R, Arias-Monroy LG, Peralta-Pedrero ML, Lázaro-Castillo JL, León-Ávila JL, Benítez-Aréchiga ZM, Jáuregui-Ruiz O, Yáñez-Gutiérrez L, Manrique-Valle M

Language: Spanish
References: 44
Page: 453-463
PDF size: 74.22 Kb.


ABSTRACT

Patent ductus arteriosus (PDA) is the most common congenital heart disease in Mexico. The clinical manifestations of the PCA are from asymptomatic patients to the presence of heart failure. Its management should be individualized based on clinical, hemodynamic data and presence of pulmonary hypertension. Our objective was to provide current medical recommendations based on the best, available scientific evidence for the diagnosis, study and therapeutic decisions of the PCA. Established a standardized sequence to search for Practice Guidelines, based on the clinical questions about PCA diagnosis and treatment. Most of the recommendations were taken from selected guidelines and supplemented with the remaining material. The information is expressed in levels of evidence (E) and grade of recommendation (R) according to the characteristics of the study design and type of publications. Currently produces large amounts of medical information in a relatively short period of time which is necessary to have evidence-based CPG to facilitate and standardize the diagnostic decision-treatment to provide better care for children and adults with PCA.


REFERENCES

  1. Vázquez-Antona CA, Vallejo M, Becerra-Becerra R, González A, Buendía-Hernández A, Vargas-Barrón J. Tratamiento de conducto arterioso permeable. Comparación de costos del cierre quirúrgico y transcateterismo en una institución pública. Arch Cardiol Mex 2004;74(4):276-282.

  2. Baduí ED, Domínguez AC, Galindo LV. Aspectos epidemiológicos de las cardiopatías congénitas en México. En: Sociedad Mexicana de Cardiología, editor. Tópicos de interés de la Tercera Reunión Estatutaria, Epidemiología de las enfermedades cardiovaculares en México: Piensa; 1992. p. 67-77.

  3. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008;153(6):807-813.

  4. Calderón-Colmenero J, Flores A, Ramírez S, Patiño-Bahena E, Zabal C, García-Montes JA, et al. Resultados en la corrección quirúrgica de la cardiopatía congénita en el síndrome de Down. Arch Cardiol Mex 2004;74(1):39-44.

  5. De-Rubens-Figueroa J, Del Pozzo-Magaña B, Pablos- Hach JL, Calderón-Jiménez C, Castrejón-Urbina R. Malformaciones cardíacas en los niños con síndrome de Down. Rev Esp Cardiol 2003;56(9):894-899.

  6. Atiq M, Aslam N, Kazmi KA. Transcatheter closure of smallto- large patent ductus arteriosus with different devices: queries and challenges. J Invasive Cardiol 2007;19(7):295- 298.

  7. Santiago J, Acuña M, Arispe E, Camargo R, Neves J, Arnoni D, et al. Right patent ductus arteriosus with an ipsilateral aortic arch: percutaneous closure with Amplatzer devices. Rev Esp Cardiol 2007;60(3):319-322.

  8. Matsui H, McCarthy KP, Ho SY. Morphology of the patent arterial duct: features relevant to treatment. Images Paediatr Cardiol 2008;10(1):27-38.

  9. Hurtado-Martínez JA, Teruel-Carrillo F, García-Alberola A, Valdés-Mas M, Valdés-Chavarri M. Cardiopatías congénitas en el adulto. Medicine 2005;9(37):2463-2470.

  10. Rao PS. Percutaneous closure of patent ductus arteriosus: state of the art. J Invasive Cardiol 2007;19(7):299-302.

  11. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. Circulation 2008;118:2395- 2451. [Acceso abril de 2010]. Disponible en http://circ. ahajournals.org/cgi/content/short/118/23/e714

  12. Maroto-Monedero C, Camino-López M, Girona-Comas JM, Malo-Concepción P; Sociedad Española de Cardiología. Guías de práctica clínica de la Sociedad Española de Cardiología en las cardiopatías congénitas del recién nacido. Rev Esp Cardiol 2001;54(1):49-66. Disponible en http://www.revespcardiol.org/es/revistas/ revista-espa%C3%B1ola-cardiologia-25/guias-practicaclinica- sociedad-espa%C3%B1ola-cardiologia-las- 13035-guias-practica-clinica-2001

  13. ESC Guidelines for the Management of grown-up congenital heart disease. (New version 2010). Eur Heart J 2010; 31:2915-2957. Doi:1093eurheart/ehq249. [Acceso abril de 2010]. Disponible en http://www.escardio.org/guidelines- surveys/esc-guidelines/GuidelinesDocuments/ guidelines-GUCH-FT.pdf

  14. Mani A, Radhakrishnan J, Farhi A, Carew KS, Warnes CA, Nelson-Williams C, et al. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. PNAS 2005;102 (8):2975-2979. [Acceso enero de 2010]. Disponible en http://www.pnas.org/content/102/8/2975.full.pdf+html

  15. Forsey JT, Elmasry OA, Martin RP. Patent arterial duct. Orphanet J Rare Dis 2009;4:17. [Acceso abril de 2010]. Disponible en http://www.biomedcentral.com/content/pdf/ 1750-1172-4-17.pdf

  16. Chia SE, Shi LM. Review of recent epidemiological studies on paternal occupations and birth defects. Occup Environ Med 2002;59(3):149-155.

  17. Goitein O, Fuhrman CR, Lacormis JM. Incidental finding on MDCT of patent ductus arteriosus: use of CT and MRI to assess clinical importance. AJR Am J Roentgenol 2005; 184(6):1924-1931.

  18. Sullivan MM, Theleman P, Choi JW. Percutaneous closure of patent ductus arteriosus in an asymptomatic adult. Proc (Bayl Univ Med Cent) 2008;21(4):386-388. [Acceso abril de 2010]. Disponible en http://www.baylorhealth.edu/ proceedings/21_4/21_4_sullivan.pdf

  19. Working Group on Management of Congenital Heart Disease in India. Consensus on Timing of intervention for common congenital heart disease. Indian Pediatr 2008;45 (2):117-126.

  20. Doyle T, Kavanaugh-McHugh A, Graham TP. Clinical manifestations and diagnosis of patent ductus arteriosus. UpToDate 2009 [Acceso enero de 2010]. Disponible en http://www.utdol.com/patients/content/topic.do?topicKey =~rFjXi1HGQtKmgs

  21. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006;114:1873-1882. Disponible en http://circ. ahajournals.org/content/114/17/1873.full

  22. Vázquez-Antona CA. Papel del ecocardiograma en el adulto con cardiopatía congénita. Arch Cardiol Mex 2002; 72(s1):S226-S232.

  23. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography. [Acceso abril de 2010], Disponible en http://circ.ahajournals.org/content/108/9/1146.full

  24. Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J, Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J. Doi:10.1093/eurheartj/ehp586. [Acceso abril de 2010]. Disponible en http://eurheartj. oxfordjournals.org/content/early/2010/01/11/eurheartj. ehp586.full

  25. Thanopoulos BD, Hakim FA, Hiari A, Goussous Y, Basta E, Zarayelyan AA, et al. Further experience with transcatheter closure of the patent ductus arteriosus using the Amplatzer Duch occluder. J Am Coll Cardiol 2000;35(4): 1016-1021.

  26. Cassidy HD, Cassidy LA, Blackshear LJ. Incidental discovery of a patent ductus arteriosus in adults. J Am Borrad Fam Med 2009:22(2):214-218.

  27. Rashid A, Ivy DD. Pulmonary hypertension in children. Curr Paediatrics 2006;16(4):237-247.

  28. Guías de práctica clínica para el diagnóstico y tratamiento de la hipertensión arterial pulmonar. Rev Esp Cardiol 2005;58(5):523-566.

  29. Leos-García A, Chavarría-Martínez U. Hipertensión pulmonar: definición, clasificación, abordaje diagnóstico y actualidades en el tratamiento. Med Univer 2006;8(33):231-241.

  30. Robledo-Pascual JC, Rosas-Romero MJ, Campos-Cerda R, Morales-Blanhir JE. Test de reactividad vascular pulmonar. Neumología y Cirugía de Tórax 2006;65(S4):S43-S50.

  31. Bennhagen RG, Benson LN. Silent and audible persistent ductus arteriosus: an angiographic study. Pediatr Cardiol 2003;24(1):27-30.

  32. Celebi A, Erdem A, Cokugras H, Ahunbay G. Infective endarteritis in a 2 month old infant associated with silent patent ductus arteriosus. Anadolu Kardiyol Derg 2007;7 (3):325-327.

  33. Onji K, Matsuura W. Pulmonary endarteritis and subsequent pulmonary embolism associated with clinically silent patent ductus arteriosus. Intern Med 2007;46(19):1663-1667.

  34. Rigby ML. Closure of a large patent ductus arteriosus in adults: first do no harm. Heart 2007;93(4):417-418.

  35. Leon-Wyss JL, Vida VL, Veras O, Vides I, Gaitan G, O’Connell M, et al. Modified extrapleural ligation of patent ductus arteriosus: a convenient surgical approach in a developing country. Ann Thorac Surg 2005;79(2):632-635.

  36. Giroud JM, Jacobs JP. Evolution of strategies for management of the patent arterial duct. Cardiol Young 2007;17 (Suppl 2):68-74.

  37. Medscape. [Sede web]. Mancini MC editor. Patent ductus arteriosus, surgical treatment 2009. [Acceso abril de 2010]. Disponible en http://emedicine.medscape.com/article/ 904895-overview

  38. Bensky AS, Raines KH, Hines MH. Late follow-up after thoracoscopic ductal ligation. Am J Cardiol 2000;86(3):360- 361.

  39. Villa E, Vanden EF, Le Bret E, Folliguet T, Laborde F. Paediatric video-assisted thoracoscopic clipping of patent ductus arteriosus: experience in more than 700 cases. Eur J Cardiothoracic Surg 2004;25(3):387-393.

  40. Nezafati MH, Sotani G, Vedadian A. Video-assisted ductal closure with new modifications: minimally invasive, maximally effective, 1 300 cases. Ann Thorac Surg 2007;84(4):1343-1348.

  41. Dutta S, Mihailovic A, Benson L, Kantor PF, Fitzgerald PG, Walton JM, et al. Thoracoscopic ligation versus coil occlusion for patent ductus arteriosus: a matched cohort study of outcomes and cost. Surg Endosc 2008;22(7):1643-1648.

  42. Lázaro-Castillo JL, Munayer-Calderón J, Aldana-Pérez T, San Luis-Miranda R, Maza-Juárez G, Ramírez-Reyes H, et al. Estudio comparativo entre dispositivos de rashkind, grifka y coil para el cierre percutáneo del conducto arterioso. Arch Inst Cardiol Mex 2000;70(2):167-172.

  43. Grech V, DeGiovanni JV. Flipper coil closure of patent ductus arteriosus. Images Paediatr Cardiol 2007;9(2):1-15.

  44. Gamboa R, Mollón FP, Ríos-Méndez RE, Arroyo GM, Fogel A, Villa D. Cierre del ductus arterioso permeable con un nuevo tipo de dispositivo: Nit-Occlud. Rev Esp Cardiol 2007;60(4):445-448.




2020     |     www.medigraphic.com